IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

Overview Fund Activity

67 hedge funds and large institutions have $47.9M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-8
Holders Change %
-10.67%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
22
Reduced
19
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IWC
Integrated Wealth Concepts
Massachusetts
$1.56M
2
Bank of America
Bank of America
North Carolina
$6.44M
3
Morgan Stanley
Morgan Stanley
New York
$4.33M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$1.77M
5
PCA
Pallas Capital Advisors
Massachusetts
$428K

Top Sellers

1
WBG
Wharton Business Group
Pennsylvania
$6.15M
2
WAP
Wealthcare Advisory Partners
Pennsylvania
$4.31M
3
SFFS
Stonehage Fleming Financial Services
Jersey
$0
4
LPL Financial
LPL Financial
California
$1.25M
5
AWM
Apollon Wealth Management
South Carolina
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
76
Simplex Trading
Illinois
– -$3K -145 Closed
Fidelity Investments
77
Fidelity Investments
Massachusetts
– -$1.61K -69 Closed
JPMorgan Chase & Co
78
JPMorgan Chase & Co
New York
– -$15 -19 Closed
1 2 3
4